by Joseph A. DiMasi, Ph.D. Tufts Center for the Study of Drug Development Tufts University* A background report prepared for the Department of health and Human Services' Conference on Pharmaceutical Pricing Practices, Utilization and Costs August 8-9, 2000
Prescription Drugs & Other Medical Products
Drugs and other medical products greatly impact human health and the health care system. ASPE conducts a variety of research in this area, including work related to medical product development and regulation; medical product markets, pricing and competition; prescription drug benefits and spending on medical products; medical product supply chains; and medical product safety.
Noteworthy
Reports
Displaying 171 - 178 of 178. 10 per page. Page 18.
Advanced SearchCost Control for Prescription Drug Programs: Pharmacy Benefit Manager (PBM) Efforts, Effects, and Implications
by David H. Kreling, Ph.D., R.Ph. Sonderegger Research Center University of Wisconsin School of Pharmacy A background report prepared for the Department of Health and Human Services' Conference on Pharmaceutical Pricing Practices, Utilization and Costs August 8-9, 2000 Leavey Conference Center, Georgetown University
Medicare+Choice: Payment and Service Areas
The Balanced Budget Act of 1997 included a number of changes to Medicare managed care. The newly created Medicare+Choice program differs from its predecessor with regard to payment policies, enrollment and disenrollment policies, and the types of plans that can contract to provide care to Medicare beneficiaries.
Prescription Drug Coverage, Spending, Utilization, and Prices
Prescription drugs play an ever-increasing role in modern medicine. New medications are improving health outcomes and quality of life, replacing surgery and other invasive treatments, and quickening recovery for patients who receive these treatments. As important as prescription drugs are, not everyone has access to them.
Report to the President: Prescription Drug Coverage, Spending, Utilization, and Prices.
Executive Summary
Prescription drugs play an ever-increasing role in modern medicine. New medications are improving health outcomes and quality of life, replacing surgery and other invasive treatments, and quickening recovery for patients who receive these treatments. As important as prescription drugs are, not everyone has access to them.
State Regulatory Experience with Provider-Sponsored Organizations
This report describes the experience of selected state governments in regulating provider-owned health care delivery systems that accept insurance risk for the provision or arrangement of health care services. We refer to these entities as Provider-Sponsored Organizations (PSOs).
An Exploratory Study of Barriers and Incentives to Improving Labor Force Participation Among Persons with Significant Disabilities: Final Report
U.S. Department of Health and Human Services